These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

145 related articles for article (PubMed ID: 32560289)

  • 1. Comparison between Colistin Sulfate Dry Powder and Solution for Pulmonary Delivery.
    Tewes F; Brillault J; Gregoire N; Olivier JC; Lamarche I; Adier C; Healy AM; Marchand S
    Pharmaceutics; 2020 Jun; 12(6):. PubMed ID: 32560289
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Pulmonary Pharmacokinetics of Colistin following Administration of Dry Powder Aerosols in Rats.
    Lin YW; Zhou QT; Hu Y; Onufrak NJ; Sun S; Wang J; Forrest A; Chan HK; Li J
    Antimicrob Agents Chemother; 2017 Nov; 61(11):. PubMed ID: 28807905
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Pulmonary pharmacokinetics of levofloxacin in rats after aerosolization of immediate-release chitosan or sustained-release PLGA microspheres.
    Gaspar MC; Grégoire N; Sousa JJ; Pais AA; Lamarche I; Gobin P; Olivier JC; Marchand S; Couet W
    Eur J Pharm Sci; 2016 Oct; 93():184-91. PubMed ID: 27531420
    [TBL] [Abstract][Full Text] [Related]  

  • 4. New aerosol formulation to control ciprofloxacin pulmonary concentration.
    Lamy B; Tewes F; Serrano DR; Lamarche I; Gobin P; Couet W; Healy AM; Marchand S
    J Control Release; 2018 Feb; 271():118-126. PubMed ID: 29277683
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Pulmonary delivery of growth hormone using dry powders and visualization of its local fate in rats.
    Bosquillon C; Préat V; Vanbever R
    J Control Release; 2004 Apr; 96(2):233-44. PubMed ID: 15081215
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Novel Inhaled Combination Powder Containing Amorphous Colistin and Crystalline Rifapentine with Enhanced Antimicrobial Activities against Planktonic Cells and Biofilm of Pseudomonas aeruginosa for Respiratory Infections.
    Zhou QT; Sun SP; Chan JG; Wang P; Barraud N; Rice SA; Wang J; Li J; Chan HK
    Mol Pharm; 2015 Aug; 12(8):2594-603. PubMed ID: 25423590
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Improved Physical Stability and Aerosolization of Inhalable Amorphous Ciprofloxacin Powder Formulations by Incorporating Synergistic Colistin.
    Shetty N; Ahn P; Park H; Bhujbal S; Zemlyanov D; Cavallaro A; Mangal S; Li J; Zhou QT
    Mol Pharm; 2018 Sep; 15(9):4004-4020. PubMed ID: 30028947
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Inhalable co-amorphous budesonide-arginine dry powders prepared by spray drying.
    Lu W; Rades T; Rantanen J; Yang M
    Int J Pharm; 2019 Jun; 565():1-8. PubMed ID: 30999050
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Design and evaluation of novel inhalable sildenafil citrate spray-dried microparticles for pulmonary arterial hypertension.
    Shahin HI; Vinjamuri BP; Mahmoud AA; Shamma RN; Mansour SM; Ammar HO; Ghorab MM; Chougule MB; Chablani L
    J Control Release; 2019 May; 302():126-139. PubMed ID: 30940497
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Development of inhalable hyaluronan/mannitol composite dry powders for flucytosine repositioning in local therapy of lung infections.
    Costabile G; d'Angelo I; d'Emmanuele di Villa Bianca R; Mitidieri E; Pompili B; Del Porto P; Leoni L; Visca P; Miro A; Quaglia F; Imperi F; Sorrentino R; Ungaro F
    J Control Release; 2016 Sep; 238():80-91. PubMed ID: 27449745
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Pharmacokinetics/Pharmacodynamics of Pulmonary Delivery of Colistin against Pseudomonas aeruginosa in a Mouse Lung Infection Model.
    Lin YW; Zhou QT; Cheah SE; Zhao J; Chen K; Wang J; Chan HK; Li J
    Antimicrob Agents Chemother; 2017 Mar; 61(3):. PubMed ID: 28031207
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Pharmacokinetics of Inhaled Rifampicin Porous Particles for Tuberculosis Treatment: Insight into Rifampicin Absorption from the Lungs of Guinea Pigs.
    Garcia Contreras L; Sung J; Ibrahim M; Elbert K; Edwards D; Hickey A
    Mol Pharm; 2015 Aug; 12(8):2642-50. PubMed ID: 25942002
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Pulmonary delivery of pyrazinamide-loaded large porous particles.
    Pham DD; Grégoire N; Couet W; Gueutin C; Fattal E; Tsapis N
    Eur J Pharm Biopharm; 2015 Aug; 94():241-50. PubMed ID: 26036447
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Tadalafil nanocomposites as a dry powder formulation for inhalation, a new strategy for pulmonary arterial hypertension treatment.
    Teymouri Rad R; Dadashzadeh S; Vatanara A; Alavi S; Ghasemian E; Mortazavi SA
    Eur J Pharm Sci; 2019 May; 133():275-286. PubMed ID: 30953751
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Porous and highly dispersible voriconazole dry powders produced by spray freeze drying for pulmonary delivery with efficient lung deposition.
    Liao Q; Yip L; Chow MYT; Chow SF; Chan HK; Kwok PCL; Lam JKW
    Int J Pharm; 2019 Apr; 560():144-154. PubMed ID: 30731259
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Dry powder inhalation of antibiotics in cystic fibrosis therapy: part 2. Inhalation of a novel colistin dry powder formulation: a feasibility study in healthy volunteers and patients.
    Le Brun PP; de Boer AH; Mannes GP; de Fraîture DM; Brimicombe RW; Touw DJ; Vinks AA; Frijlink HW; Heijerman HG
    Eur J Pharm Biopharm; 2002 Jul; 54(1):25-32. PubMed ID: 12084499
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Development of an inhaled controlled release voriconazole dry powder formulation for the treatment of respiratory fungal infection.
    Arora S; Haghi M; Loo CY; Traini D; Young PM; Jain S
    Mol Pharm; 2015 Jun; 12(6):2001-9. PubMed ID: 25923171
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Advanced spray-dried design, physicochemical characterization, and aerosol dispersion performance of vancomycin and clarithromycin multifunctional controlled release particles for targeted respiratory delivery as dry powder inhalation aerosols.
    Park CW; Li X; Vogt FG; Hayes D; Zwischenberger JB; Park ES; Mansour HM
    Int J Pharm; 2013 Oct; 455(1-2):374-92. PubMed ID: 23820131
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Dry powder inhalation of antibiotics in cystic fibrosis therapy, part 1: development of a powder formulation with colistin sulfate for a special test inhaler with an air classifier as de-agglomeration principle.
    de Boer AH; Le Brun PP; van der Woude HG; Hagedoorn P; Heijerman HG; Frijlink HW
    Eur J Pharm Biopharm; 2002 Jul; 54(1):17-24. PubMed ID: 12084498
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Dry powder inhaler of colistimethate sodium for lung infections in cystic fibrosis: optimization of powder construction.
    Kozáková J; Altay A; Ždímal V; Mašková L; Sonvico F; Quarta E; Rossi A; Buttini F; Colombo G
    Drug Dev Ind Pharm; 2019 Oct; 45(10):1664-1673. PubMed ID: 31389270
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.